|
08:35
|
--- Welcome ---
|
|
08:50
|
Introduction, minutes from the 12th Collaboration Board, Agenda
(40/S2-C01 - Salle Curie)
|
|
09:00
|
MEDICIS Collaboration: different schemes of operation (MoU, Budget & Financial Report)
-
Agata Beata Rozycka
(CERN)
Alessandro Raimondo
(CERN)
(40/S2-C01 - Salle Curie)
|
|
09:20
|
Future of PRISMAP: PRISMAP+
-
Thierry Stora
(CERN)
(40/S2-C01 - Salle Curie)
|
|
09:35
|
Future of MEDICIS
-
Thierry Stora
(CERN) Dr
Simone Gilardoni
(CERN)
(40/S2-C01 - Salle Curie)
|
|
09:50
|
MEDICIS Overview since past board and insights for next year 2025
-
Charlotte Duchemin
(CERN SY/STI/RBS)
(40/S2-C01 - Salle Curie)
|
|
10:10
|
--- Coffee Break ---
|
|
10:30
|
Recent achievements within the collaboration
(until 11:20)
(40/S2-C01 - Salle Curie)
|
|
10:30
|
Rechelation of daughter nuclides from 212Pb and 225Ac with tailored chelators
- Dr
Marc PRETZE
(40/S2-C01 - Salle Curie)
|
|
10:45
|
Experiences on Macropa for TAT with the perfect matched pair 203Pb/212Pb
- Dr
Constantin MAMAT
(40/S2-C01 - Salle Curie)
|
|
11:00
|
MED-015 - Sc radionuclide production and mass separation
-
Edgars Mamis
(40/S2-C01 - Salle Curie)
|
|
11:15
|
New projects
(until 12:15)
(40/S2-C01 - Salle Curie)
|
|
11:15
|
MED-040 Decay data for Ac-226
-
Sean Collins
(National Physical Laboratory)
(40/S2-C01 - Salle Curie)
|
|
11:35
|
MED-041 Detection of 225Ac produced in high-energy photo-spallation of 232Th
-
Giuseppe Lorusso
(40/S2-C01 - Salle Curie)
|
|
11:55
|
Investigating the potential of Ac-225 labelled pharmaceuticals for Targeted Alpha Therapy: Pre-clinical & Clinical Evaluation
- Dr
Shakera Rizvi
(Islamabad)
(40/S2-C01 - Salle Curie)
|
